ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 98.40
-2.20 (-2.19%)
Apr 21, 2026, 3:44 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €7.97 billion as of April 21, 2026. Its market cap has increased by 2,348.54% in one year.
Market Cap
7.97B
Enterprise Value
7.47B
Revenue
4.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€98.40
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 7.97B, an increase of 3,841.18%. That is a compound annual growth rate of 40.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 7.97B | -14.99% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.35B |
| DBV Technologies | 1.06B |
| Inventiva | 991.80M |
| MedinCell | 858.11M |
| Valneva SE | 454.36M |
| Genfit | 454.13M |
| Cellectis | 254.21M |
| Transgene | 208.70M |